The NPM1 Gene Fragment Analysis Test is a specialized diagnostic examination conducted at DNA Labs UAE, designed to detect mutations in the NPM1 gene. These mutations are significant because they are often associated with acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. By analyzing fragments of the NPM1 gene, this test helps in identifying specific genetic alterations that can influence treatment decisions and prognostic assessments for patients diagnosed with AML.
The cost of the NPM1 Gene Fragment Analysis Test at DNA Labs UAE is 1800 AED. This test is a crucial step in the personalized medicine approach, offering insights that can lead to targeted therapies tailored to the genetic profile of the individual's cancer. Conducted in a state-of-the-art facility, the test ensures accuracy and reliability, providing essential information for both patients and healthcare providers in the management of acute myeloid leukemia.
The NTRK1 Test is a specialized diagnostic procedure designed to detect alterations in the NTRK1 gene, which can play a crucial role in the development and progression of various cancers. This gene encodes for a protein that is involved in the growth and division of cells, and mutations in NTRK1 can lead to abnormal cell growth, potentially resulting in cancer. The test is particularly significant for patients with tumors that may be driven by NTRK gene fusions, as it can help in guiding targeted therapy options.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the NTRK1 Test is performed using sophisticated molecular techniques to ensure accuracy and reliability. The cost of the test is 1800 AED, reflecting the comprehensive analysis and detailed insights it provides. By identifying NTRK1 gene alterations, healthcare providers can tailor treatment strategies more effectively, offering hope for better outcomes in patients affected by cancers associated with these genetic changes.
The NTRK2 test is a specialized diagnostic procedure aimed at detecting genetic alterations in the NTRK2 gene, which can play a significant role in the development and progression of various types of cancers. This gene encodes for a protein that is involved in the growth and survival of nerve cells, and mutations within this gene can lead to abnormal cell growth and cancer. The test is particularly relevant for patients who may benefit from targeted therapy, as identifying NTRK2 gene alterations can help in customizing treatment plans to improve outcomes.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the NTRK2 test utilizes advanced molecular techniques to accurately identify mutations within the NTRK2 gene. The test is conducted under stringent laboratory conditions to ensure high levels of accuracy and reliability. With a cost of 1800 AED, the test is an investment in personalized medicine, offering crucial information that can guide treatment decisions and potentially lead to better patient outcomes. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring that patients receive comprehensive and precise genetic testing services.
The NTRK3 test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect alterations in the NTRK3 gene, which can play a crucial role in the development and progression of certain types of cancer. This gene is involved in the encoding of neurotrophic tyrosine receptor kinase type 3, a protein that can affect cell growth and division. Alterations or mutations in the NTRK3 gene are associated with various cancers, making this test an important part of personalized cancer treatment planning.
By identifying specific genetic mutations, healthcare providers can tailor treatment strategies to target the genetic makeup of the cancer, potentially improving patient outcomes. The NTRK3 test is performed using a sample of the patient's tissue or blood, utilizing advanced genetic sequencing technologies to accurately identify mutations in the NTRK3 gene.
At DNA Labs UAE, the cost of the NTRK3 test is set at 1800 AED. The test is conducted in a state-of-the-art laboratory setting by experienced professionals, ensuring high-quality and reliable results. This test represents a critical step forward in the field of precision medicine, offering hope for more effective and personalized cancer treatment options.
The PIK3CA Mutation Analysis Exon 7, 9, and 20 Test is a specialized diagnostic procedure designed to identify mutations in the PIK3CA gene, particularly focusing on exons 7, 9, and 20. This gene plays a crucial role in cell growth and division, and mutations within it are often associated with various cancers, including breast, colorectal, and endometrial cancers. By pinpointing specific alterations in these exons, healthcare professionals can gain valuable insights into the molecular underpinnings of a patient's cancer, which can, in turn, guide personalized treatment decisions.
The test is conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art genetic testing services. The cost of the test is 1800 AED, which reflects the comprehensive analysis and detailed insights it provides. By utilizing advanced molecular techniques, DNA Labs UAE ensures accurate and reliable results, making the PIK3CA Mutation Analysis Exon 7, 9, and 20 Test a valuable tool in the arsenal against cancer.
The RET NSCLC Test is a specialized diagnostic procedure aimed at detecting rearrangements in the RET gene, which are implicated in the development of non-small cell lung cancer (NSCLC). This test is crucial for patients diagnosed with NSCLC as it helps in identifying whether they are candidates for targeted therapy that specifically addresses RET gene mutations. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers precise and reliable results. The cost of the RET NSCLC Test is 1800 AED, reflecting the sophisticated technology and expertise involved in conducting this advanced molecular diagnostic test. By identifying the genetic alterations in the RET gene, healthcare providers can tailor treatment plans to improve outcomes and quality of life for NSCLC patients.
The Synovial Sarcoma SS18 Test is a specialized diagnostic tool used for the detection of specific genetic abnormalities associated with synovial sarcoma, a rare type of cancer that usually occurs near the joints of the arm, neck, or leg but can appear in any part of the body. This test focuses on identifying the SS18-SSX fusion gene, a hallmark of synovial sarcoma, which results from the translocation between chromosome X and chromosome 18. Accurate detection of this genetic marker is crucial for confirming the diagnosis of synovial sarcoma, guiding treatment decisions, and assessing prognosis.
Performed at DNA Labs UAE, a leading facility known for its advanced genetic testing capabilities, the Synovial Sarcoma SS18 Test offers patients and healthcare providers a reliable resource for diagnosing this rare cancer. The test is priced at 1800 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. By choosing DNA Labs UAE for this critical test, patients can expect high-quality diagnostic services, aiding in the effective management of synovial sarcoma through tailored treatment approaches.
Targeted Mutation Analysis 1 Mutation Test, available at DNA Labs UAE, is a specialized genetic testing process priced at 1800 AED. This test is designed to identify specific mutations within an individual's DNA, providing critical insights into genetic disorders or the risk of developing certain diseases. By focusing on a particular mutation, the test offers precise information that can aid in the diagnosis, treatment planning, or risk assessment for genetic conditions. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial tool for individuals seeking to understand their genetic health profile concerning specific genetic mutations.
The BCR-ABL Major Quantitative Test is a crucial diagnostic and monitoring tool used in the management of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This test specifically measures the amount of BCR-ABL fusion gene transcript in the blood or bone marrow. The presence of this gene results from a chromosomal abnormality known as the Philadelphia chromosome, which is a hallmark of CML and can also be present in ALL patients.
The test employs quantitative real-time PCR technology, allowing for the precise quantification of BCR-ABL gene transcripts. This level of precision is vital for assessing the disease's progression, evaluating patient response to therapy, and detecting minimal residual disease that may indicate a relapse.
At DNA Labs UAE, the BCR-ABL Major Quantitative Test is offered at a cost of 1800 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs highly skilled professionals to ensure the accuracy and reliability of test results. This test is a key component in the personalized treatment plans for leukemia patients, enabling healthcare providers to tailor therapies based on the genetic profile of the individual's disease and monitor their response over time.
Immunophenotyping by Flow Cytometry is a critical diagnostic tool used in the identification and classification of leukemia, a group of blood cancers that originate in the bone marrow. The "Leukemia Diagnostic Panel Customized Any 10 Markers Test" is a specialized test offered by DNA Labs UAE, designed to provide a comprehensive analysis of a patient's blood or bone marrow sample by evaluating any 10 specific markers chosen based on the individual's clinical presentation and suspected type of leukemia.
This test employs flow cytometry, a technology that enables the detailed characterization of cells based on their physical and chemical properties. By using antibodies tagged with fluorescent dyes that bind to specific antigens on the surface of the cells, flow cytometry can distinguish between different cell types and identify abnormal populations, which is crucial for diagnosing leukemia.
The selection of markers is tailored to each patient, allowing for a highly personalized assessment that can inform treatment decisions and prognosis. The test cost is set at 2190 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis.
Conducted at DNA Labs UAE, a facility known for its state-of-the-art diagnostic services, this test is part of a comprehensive approach to leukemia diagnosis, ensuring that patients receive accurate, timely, and personalized diagnostic information. This is essential for initiating the most effective treatment plans and improving patient outcomes in the battle against leukemia.
